-
1
-
-
33947397636
-
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn's Disease in Children
-
DOI 10.1053/j.gastro.2006.12.003, PII S0016508506025613
-
Hyams J, Crandall W, Kugathasan S, et al. Induction and maintenance inflix-imab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007;132:863-73 (Pubitemid 46454266)
-
(2007)
Gastroenterology
, vol.132
, Issue.3
, pp. 863-873
-
-
Hyams, J.1
Crandall, W.2
Kugathasan, S.3
Griffiths, A.4
Olson, A.5
Johanns, J.6
Liu, G.7
Travers, S.8
Heuschkel, R.9
Markowitz, J.10
Cohen, S.11
Winter, H.12
Veereman-Wauters, G.13
Ferry, G.14
Baldassano, R.15
-
2
-
-
0025796809
-
Development and validation ofapediatric Crohn's disease activity index
-
Hyams JS, Ferry GD, Mandel FS,et al. Development and validation ofapediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47
-
(1991)
J Pediatr Gastroenterol Nutr
, vol.12
, pp. 439-47
-
-
Hyams, J.S.1
Ferry, G.D.2
Mandel, F.S.3
-
3
-
-
0026525024
-
Relationship of common laboratory parameters to the activity of Crohn's disease in children
-
Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-22
-
(1992)
J Pediatr Gastroenterol Nutr
, vol.14
, pp. 216-22
-
-
Hyams, J.S.1
Mandel, F.2
Ferry, G.D.3
-
4
-
-
26044457921
-
Evaluation of the pediatric Crohn disease activity index: A prospective multicenter experience
-
DOI 10.1097/01.mpg.0000183350.46795.42
-
Hyams J, Markowitz J, Otley A, et al. Evaluation of the pediatric Crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005;41:416-21 (Pubitemid 41407602)
-
(2005)
Journal of Pediatric Gastroenterology and Nutrition
, vol.41
, Issue.4
, pp. 416-421
-
-
Hyams, J.1
Markowitz, J.2
Otley, A.3
Rosh, J.4
Mack, D.5
Bousvaros, A.6
Kugathasan, S.7
Pfefferkorn, M.8
Tolia, V.9
Evans, J.10
Treem, W.11
Wyllie, R.12
Rothbaum, R.13
Del Rosario, J.14
Katz, A.15
Mezoff, A.16
Oliva-Hemker, M.17
Lerer, T.18
Griffiths, A.19
-
5
-
-
0033016819
-
Assessing activity of pediatric Crohn's disease: Which index to use?
-
Otley A, Loonen H, Parekh N, et al. Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology 1999;116:527-31 (Pubitemid 29106759)
-
(1999)
Gastroenterology
, vol.116
, Issue.3
, pp. 527-531
-
-
Otley, A.1
Loonen, H.2
Parekh, N.3
Corey, M.4
Sherman, P.M.5
Griffiths, A.M.6
-
6
-
-
3042579454
-
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease
-
DOI 10.1016/S1542-3565(04)00238-1, PII S1542356504002381
-
Hanauer SB, Wagner CL, Bala M, et al. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gatroenterol Hepatol 2004;2:542-53 (Pubitemid 38834038)
-
(2004)
Clinical Gastroenterology and Hepatology
, vol.2
, Issue.7
, pp. 542-553
-
-
Hanauer, S.B.1
Wagner, C.L.2
Bala, M.3
Mayer, L.4
Travers, S.5
Diamond, R.H.6
Olson, A.7
Bao, W.8
Rutgeerts, P.9
-
7
-
-
79951668209
-
-
National Center for Health Statistics, Available at [Last accessed 23 August 2010]
-
National Center for Health Statistics. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/nchs/about/major/nhanes/ growthcharts/zscore/zscore.htm [Last accessed 23 August 2010]
-
-
-
-
8
-
-
69949117363
-
Mechanisms of growth impairment in pediatric Crohn's disease [review]
-
Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease [review]. Nat Rev Gastroenterol Hepatol 2009;6:513-23
-
(2009)
Nat Rev Gastroenterol Hepatol
, vol.6
, pp. 513-23
-
-
Walters, T.D.1
Griffiths, A.M.2
-
9
-
-
4644250862
-
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
-
DOI 10.1111/j.1365-2036.2004.02152.x
-
Franchimont N, Putzeys V, Collette J, et al. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther 2004;20:607-14 (Pubitemid 39279048)
-
(2004)
Alimentary Pharmacology and Therapeutics
, vol.20
, Issue.6
, pp. 607-614
-
-
Franchimont, N.1
Putzeys, V.2
Collette, J.3
Vermeire, S.4
Rutgeerts, P.5
De Vos, M.6
Van Gossum, A.7
Franchimont, D.8
Fiasse, R.9
Pelckmansj, P.10
Malaise, M.11
Belaiche, J.12
Louis, E.13
-
10
-
-
33644976247
-
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease
-
DOI 10.1097/01.mcg.0000190762.80615.d4, PII 0000483620060100000011
-
Abreu MT, Geller JL, Vasiliauskas EA, et al. Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease. J Clin Gastroenterol 2006;40:55-63 (Pubitemid 44378078)
-
(2006)
Journal of Clinical Gastroenterology
, vol.40
, Issue.1
, pp. 55-63
-
-
Abreu, M.T.1
Geller, J.L.2
Vasiliauskas, E.A.3
Kam, L.Y.4
Vora, P.5
Martyak, L.A.6
Yang, H.7
Hu, B.8
Lin, Y.-C.9
Keenan, G.10
Price, J.11
Landers, C.J.12
Adams, J.S.13
Targan, S.R.14
-
11
-
-
36749098487
-
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy
-
DOI 10.1002/ibd.20234
-
Miheller P, Mü zes G, Rácz K, et al. Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis 2007; 13:1379-84 (Pubitemid 350206849)
-
(2007)
Inflammatory Bowel Diseases
, vol.13
, Issue.11
, pp. 1379-1384
-
-
Miheller, P.1
Muzes, G.2
Racz, K.3
Blazovits, A.4
Lakatos, P.5
Herszenyi, L.6
Tulassay, Z.7
-
12
-
-
57149094224
-
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: Results of the REACH study
-
Thayu M, Leonard MB, Hyams JS, et al. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study. Clin Gastroenterol Hepatol 2008;6:1378-84
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 1378-84
-
-
Thayu, M.1
Leonard, M.B.2
Hyams, J.S.3
-
13
-
-
67650234230
-
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease
-
Hyams JS, Lerer T, Griffiths A, et al. Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis 2009; 15:816-22
-
(2009)
Inflamm Bowel Dis
, vol.15
, pp. 816-22
-
-
Hyams, J.S.1
Lerer, T.2
Griffiths, A.3
|